Ignite Creation Date:
2024-07-17 @ 11:17 AM
Last Modification Date:
2024-10-26 @ 3:34 PM
Study NCT ID:
NCT06493370
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-07-10
First Post:
2024-06-26
Brief Title:
Intravenous Ascorbate Plus GemcitabineCarboplatin A Novel and Cost-Effective Alternative With Evident Efficacy in Patients With Muscle Invasive Bladder Cancer
Sponsor:
University of Kansas Medical Center
Organization:
University of Kansas Medical Center
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-12-01
Start Date Type:
ESTIMATED
Primary Completion Date:
2028-12-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2030-12-01
Completion Date Type:
ESTIMATED
First Submit Date:
2024-06-26
First Submit QC Date:
None
Study First Post Date:
2024-07-10
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-07-04
Last Update Post Date:
2024-07-10
Last Update Post Date Type:
ACTUAL